25 May 2026 : Clinical Research
Perioperative Glycemic Control and Outcomes in Cardiac Surgery: A Retrospective Cohort Study
Ana Luiza Antony Gomes de Matos da Costa e SilvaDOI: 10.12659/MSM.952210
Med Sci Monit 2026; 32:e952210
Table 3 Multivariate analysis of factors associated with in-hospital mortality.
| Variable | OR (95% CI) | P value | VIF | Tolerance |
|---|---|---|---|---|
| Compliance with BGT 70–180 mg/dL* | 0.10 (0.02–0.59) | 0.011 | 1.49 | 0.671 |
| Female | 5.60 (1.09–29.10) | 0.039 | 1.13 | 0.887 |
| Age (per year) | 1.21 (1.08–1.36) | 0.002 | 2.01 | 0.496 |
| SAH | 0.08 (0.01–0.06) | 0.018 | 2.08 | 0.713 |
| Corticosteroid use | 13.21 (2.20–79.42) | 0.005 | 1.40 | 0.713 |
| Underweight | 2.37 (0.22–25.45) | 0.476 | 1.19 | 0.837 |
| Heart valve/other surgery | 0.26 (0.02–4.32) | 0.344 | 1.08 | 0.926 |
| BGT – blood glucose target; CI – confidence interval; OR – odds ratio; SAH – systemic arterial hypertension; VIF – variance inflation factor. * Defined as maintaining glucose values within this range in ≥70% of measurements. | ||||






